Ventolin inhaler

Ventolin is one of the most recognized pharmaceutical brands globally, used primarily for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The brand's active ingredient, salbutamol (known as albuterol in the US), was first developed and launched in the late 1960s.

The manufacturing of Ventolin inhalers occurs across a sophisticated global supply chain. While significant production facilities are located in the United Kingdom (notably in Evreux, France and Ware, UK), GSK operates multiple manufacturing sites worldwide to meet global demand, including locations in Australia and other regional hubs.

Ownership of the brand resides with GlaxoSmithKline (GSK), a British multinational pharmaceutical company. GSK remains the ultimate owner and distributor, managing the brand through various international subsidiaries and local partnerships to ensure compliance with regional medical regulations.